Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 03    symbols : INCY    save search
Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial
Published: 2021-03-03 (Crawled : 12:09) - prnewswire.com
LLY | $728.765 -2.3% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.38% H: 0.46% C: -0.67%
INCY | $52.45 -0.7% 530K twitter stocktwits trandingview |
Health Technology
 | | O: -0.3% H: 0.33% C: -2.94%
growth phase 3 trial baricitinib hair regrowth
Gainers vs Losers
77% 23%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
TPET | $0.4001 22.02% 35M twitter stocktwits trandingview |
n/a
SRFM 4 | $0.6 21.29% 850K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.